125 related articles for article (PubMed ID: 15694844)
1. Biological response of human diploid keratinocytes to quinone-producing compounds: role of NAD(P)H:quinone oxidoreductase 1.
Foppoli C; De Marco F; Blarzino C; Perluigi M; Cini C; Coccia R
Int J Biochem Cell Biol; 2005 Apr; 37(4):852-63. PubMed ID: 15694844
[TBL] [Abstract][Full Text] [Related]
2. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors.
Nioi P; Hayes JD
Mutat Res; 2004 Nov; 555(1-2):149-71. PubMed ID: 15476858
[TBL] [Abstract][Full Text] [Related]
3. The role of NAD(P)H:quinone oxidoreductase in quinone-mediated p21 induction in human colon carcinoma cells.
Qiu XB; Cadenas E
Arch Biochem Biophys; 1997 Oct; 346(2):241-51. PubMed ID: 9343371
[TBL] [Abstract][Full Text] [Related]
4. Role of Nad(P)h: quinone oxidoreductase in the regulation of intracellular redox state.
Mohora M
Rom J Intern Med; 2000-2001; 38-39():33-50. PubMed ID: 15529570
[TBL] [Abstract][Full Text] [Related]
5. NAD(P)H: quinone oxidoreductase 1 and its potential protective role in cardiovascular diseases and related conditions.
Zhu H; Li Y
Cardiovasc Toxicol; 2012 Mar; 12(1):39-45. PubMed ID: 21818552
[TBL] [Abstract][Full Text] [Related]
6. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.
Traver RD; Horikoshi T; Danenberg KD; Stadlbauer TH; Danenberg PV; Ross D; Gibson NW
Cancer Res; 1992 Feb; 52(4):797-802. PubMed ID: 1737339
[TBL] [Abstract][Full Text] [Related]
7. Natural and synthetic quinones and their reduction by the quinone reductase enzyme NQO1: from synthetic organic chemistry to compounds with anticancer potential.
Colucci MA; Moody CJ; Couch GD
Org Biomol Chem; 2008 Feb; 6(4):637-56. PubMed ID: 18264564
[TBL] [Abstract][Full Text] [Related]
8. Benzimidazole- and benzothiazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1.
Newsome JJ; Colucci MA; Hassani M; Beall HD; Moody CJ
Org Biomol Chem; 2007 Nov; 5(22):3665-73. PubMed ID: 17971996
[TBL] [Abstract][Full Text] [Related]
9. Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1).
Fryatt T; Pettersson HI; Gardipee WT; Bray KC; Green SJ; Slawin AM; Beall HD; Moody CJ
Bioorg Med Chem; 2004 Apr; 12(7):1667-87. PubMed ID: 15028260
[TBL] [Abstract][Full Text] [Related]
10. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger.
Siegel D; Gustafson DL; Dehn DL; Han JY; Boonchoong P; Berliner LJ; Ross D
Mol Pharmacol; 2004 May; 65(5):1238-47. PubMed ID: 15102952
[TBL] [Abstract][Full Text] [Related]
11. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.
Chen S; Knox R; Lewis AD; Friedlos F; Workman P; Deng PS; Fung M; Ebenstein D; Wu K; Tsai TM
Mol Pharmacol; 1995 May; 47(5):934-9. PubMed ID: 7746280
[TBL] [Abstract][Full Text] [Related]
12. Esculetin-induced protection of human hepatoma HepG2 cells against hydrogen peroxide is associated with the Nrf2-dependent induction of the NAD(P)H: Quinone oxidoreductase 1 gene.
Subramaniam SR; Ellis EM
Toxicol Appl Pharmacol; 2011 Jan; 250(2):130-6. PubMed ID: 20933534
[TBL] [Abstract][Full Text] [Related]
13. Indolequinone antitumor agents: correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity.
Beall HD; Winski S; Swann E; Hudnott AR; Cotterill AS; O'Sullivan N; Green SJ; Bien R; Siegel D; Ross D; Moody CJ
J Med Chem; 1998 Nov; 41(24):4755-66. PubMed ID: 9822546
[TBL] [Abstract][Full Text] [Related]
14. Problematic detoxification of estrogen quinones by NAD(P)H-dependent quinone oxidoreductase and glutathione-S-transferase.
Chandrasena RE; Edirisinghe PD; Bolton JL; Thatcher GR
Chem Res Toxicol; 2008 Jul; 21(7):1324-9. PubMed ID: 18588320
[TBL] [Abstract][Full Text] [Related]
15. Dual effects of N-acetyl-L-cysteine dependent on NQO1 activity: suppressive or promotive of 9,10-phenanthrenequinone-induced toxicity.
Toyooka T; Shinmen T; Aarts JM; Ibuki Y
Toxicol Appl Pharmacol; 2012 Nov; 264(3):404-12. PubMed ID: 22925602
[TBL] [Abstract][Full Text] [Related]
16. NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions.
van Horssen J; Schreibelt G; Bö L; Montagne L; Drukarch B; van Muiswinkel FL; de Vries HE
Free Radic Biol Med; 2006 Jul; 41(2):311-7. PubMed ID: 16814112
[TBL] [Abstract][Full Text] [Related]
17. Increased tumor necrosis factor-alpha sensitivity of MCF-7 cells transfected with NAD(P)H:quinone reductase.
Siemankowski LM; Morreale J; Butts BD; Briehl MM
Cancer Res; 2000 Jul; 60(13):3638-44. PubMed ID: 10910079
[TBL] [Abstract][Full Text] [Related]
18. Anthocyanins induce the activation of phase II enzymes through the antioxidant response element pathway against oxidative stress-induced apoptosis.
Shih PH; Yeh CT; Yen GC
J Agric Food Chem; 2007 Nov; 55(23):9427-35. PubMed ID: 17935293
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
[TBL] [Abstract][Full Text] [Related]
20. Polyphenol cytotoxicity induced by the bacterial toxin pyocyanin: role of NQO1.
Muller M
Free Radic Biol Med; 2009 Jul; 47(1):84-91. PubMed ID: 19362588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]